BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 15078490)

  • 1. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
    Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
    Kumamoto H; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas.
    Kumamoto H; Ooya K
    Virchows Arch; 2004 Feb; 444(2):164-70. PubMed ID: 14714184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p63 and p73 in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2005 Apr; 34(4):220-6. PubMed ID: 15752257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of bcl-2 family proteins in benign and malignant ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 1999 Sep; 28(8):343-9. PubMed ID: 10478958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas.
    Kumamoto H; Kimi K; Ooya K
    J Oral Pathol Med; 2001 Nov; 30(10):596-602. PubMed ID: 11722709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cell cycle-related factors in ameloblastomas.
    Kumamoto H; Kimi K; Ooya K
    J Oral Pathol Med; 2001 May; 30(5):309-15. PubMed ID: 11334468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors.
    Sharifi-Sistani N; Zartab H; Babakoohi S; Saghravanian N; Jamshidi S; Esmaili H; Mohtasham N; Zamanzadeh M; Abbaszadeh-Bidokhty H
    J Craniofac Surg; 2011 Sep; 22(5):1652-6. PubMed ID: 21959406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-beta and their receptors in epithelial odontogenic tumors.
    Kumamoto H; Yoshida M; Ooya K
    J Oral Pathol Med; 2002 Oct; 31(9):539-48. PubMed ID: 12269993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of inducible nitric oxide synthase (iNOS) and heat shock proteins (HSPs) in ameloblastomas.
    Kumamoto H; Suzuki T; Ooya K
    J Oral Pathol Med; 2002 Nov; 31(10):605-11. PubMed ID: 12406306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
    Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
    J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas.
    Kumamoto H; Ohki K; Ooya K
    J Oral Pathol Med; 2004 Mar; 33(3):185-90. PubMed ID: 15128061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2006 Mar; 35(3):183-9. PubMed ID: 16454815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.